MedTrace Logo

Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.

NCT03046511 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-02-13

No results posted yet for this study

Summary

An intraperitoneal implanted catheter is always necessary to perform Peritoneal Dialysis. Catheter insertion has been associated with infectious complication such as Exit Site Infection (ESI), Tunnel Infection and Peritonitis. The last one may lead to loss of the technique because the need of catheter removal. Most of international guidelines recommends the use of prophylactic antibiotics. Different protocols has been used, mostly intravenous single injection before the procedure. For the last 25 years our unit gives a single intraperitoneal dose of Cefazolin immediately after the catheter insertion. The aim of this study is compare the effect of a pre- operative IV dose os Cefazolin with a post- procedure intraperitoneal single dose administration of the same drug.

Conditions

  • Peritoneal Dialysis-associated Peritonitis
  • Peritoneal Dialysis Catheter Infection
  • Peritoneal Dialysis Complication

Interventions

DRUG

Cefazolin

A post- procedure administration of Cefazolin will be compared with a pre-operative intravenous dose

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Victor Frajewicki, MD · Carmel Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046511 on ClinicalTrials.gov